While research is still ongoing, here are some of the primary benefits reported from both animal studies and early human trials: 1
Mutants of the candidate residues were subsequently compared with wild-type ScGrx7 in steady-state kinetic measurements using HEDS and GSSCys as a non-glutathione and glutathione disulfide substrate, respectively
The work of Pickart and colleagues (2012, 2014) showed that GHK-Cu shifts the gene expression profile from an "aged" state toward a more "youthful" state
BPC-157 is not a drug, not a dietary supplement, not a cosmetic, and not approved by the FDA, EMA, or any other regulatory authority for use in humans or animals
Researchers have been studying Nicotinamide Adenine Dinucleotide (NAD+), a derivative of the enzyme niacin for decades
An action spectrum for melatonin suppression: evidence for a novel non-rod, non-cone photoreceptor system in humans